BackMyMD Pharmaceuticals Overview

MyMD Pharmaceuticals Accounts Payable

Track MyMD Pharmaceuticals's accounts payable ($1.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.34M

Peer trimmed avg / median

Loading

MyMD Pharmaceuticals Accounts Payable History

Loading

MyMD Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

MyMD Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

MyMD Pharmaceuticals (MYMD) FAQ

MyMD Pharmaceuticals (MYMD) currently reports a accounts payable of $1.3M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore MyMD Pharmaceuticals's accounts payable history and peer comparisons.

MyMD Pharmaceuticals's accounts payable changed from $0 to $1.3M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MyMD Pharmaceuticals reported $1.3M in accounts payable as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MyMD Pharmaceuticals, and consider following MYMD for alerts when major investors trade the stock.

MyMD Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $1.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MYMD with unrelated industries.